Infantile hemangioendothelioma treated with high dose methylprednisolone pulse therapy.
10.3346/jkms.2001.16.1.127
- Author:
Eun Ae PARK
1
;
Jung Wan SEO
;
Sun Wha LEE
;
Hae Young CHOI
;
Seung Joo LEE
Author Information
1. Department of Pediatric, College of Medicine, Ewha Womans University, Seoul, Korea. pea8639@mm.ewha.ac.kr
- Publication Type:Case Report
- Keywords:
Hemangioendothelioma;
Methylprednisolone Pulse Therapy;
Neonate
- MeSH:
Case Report;
Hemangioendothelioma/drug therapy*;
Human;
Infant, Newborn;
Liver Neoplasms/drug therapy*;
Male;
Methylprednisolone/administration & dosage*;
Skin Neoplasms/drug therapy*
- From:Journal of Korean Medical Science
2001;16(1):127-129
- CountryRepublic of Korea
- Language:English
-
Abstract:
Infantile hemangioendothelioma is a severe disease with a high mortality. It is characterized by multiple hemangioma affecting the skin and visceral organs. We report that high doses of methylprednisolone pulse therapy improved symptoms and signs of infantile hemangioendothelioma in a male neonate, and completely resolved the hepatic and cutaneous hemangioendothelioma on follow up.
